Cardiovascular Safety of ADHD Medication Treatments


Cardiovascular Safety of ADHD Medication Treatments


In this session, Dr. Rostain discusses the considerations primary care practitioners should make when working with ADHD patients and stimulant medications. Cardiovascular safety should be assessed. If a patient has cardiovascular issues, Dr. Rostain lays out clearly the protocol to be followed. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Screen for cardiovascular risk before prescribing ADHD medications
  • Discuss with your patients the medication alternatives in treating ADHD
  • Monitor your patients safely when prescribing ADHD medications
  • Refer ADHD patients out to cardiology when cardiovascular risk is identified

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

  • Category: